<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Reelin Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Reelin</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RELN</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P78536</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~388 kDa (full-length)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Extracellular, cell surface</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Reelin family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>7q22.1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cortex, hippocampus, cerebellum</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Signal peptide</td>
<td>1-27</td>
</tr>
<tr>
<td class="label">N-terminal domain</td>
<td>28-189</td>
</tr>
<tr>
<td class="label">EGF-like region</td>
<td>190-327</td>
</tr>
<tr>
<td class="label">Reelin repeats R1-R8</td>
<td>328-3460</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Recombinant Reelin</td>
<td>Protein replacement</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Increase Reelin expression</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Activate signaling pathway</td>
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Reelin Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Reelin</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RELN</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P78536</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~388 kDa (full-length)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Extracellular, cell surface</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Reelin family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>7q22.1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cortex, hippocampus, cerebellum</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Signal peptide</td>
<td>1-27</td>
</tr>
<tr>
<td class="label">N-terminal domain</td>
<td>28-189</td>
</tr>
<tr>
<td class="label">EGF-like region</td>
<td>190-327</td>
</tr>
<tr>
<td class="label">Reelin repeats R1-R8</td>
<td>328-3460</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Recombinant Reelin</td>
<td>Protein replacement</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Increase Reelin expression</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Activate signaling pathway</td>
</tr>
<tr>
<td class="label">Peptide fragments</td>
<td>Functional domains</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Apoer2/LRP8</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">VLDLR</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">Dab1</td>
<td>Adaptor protein</td>
</tr>
<tr>
<td class="label">Disabled-1</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">APP</td>
<td>Possible interaction</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-d2df6eaf" style="color:#ce93d8" title="Score: 0.44">Reelin-Mediated Cytoskeletal Stabilizati...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">120 edges</a></td>
</tr>
</table>
Reelin is a large extracellular matrix protein that plays critical roles in neuronal migration, cortical layer formation, and synaptic plasticity during brain development and in the adult brain [@darcangelo1995][@tremblay2007]. The protein is encoded by the RELN gene on chromosome 7q22.1 and is secreted by Cajal-Retzius cells in the developing cortex, as well as by certain neuronal populations in the adult brain. Reelin signaling through ApoE receptors (Apoer2/VLDLR) modulates dendritic spine morphology, synaptic function, and cognitive processes including learning and memory [@weeber2002]. Reelin dysfunction has been strongly implicated in Alzheimer's disease (AD) pathogenesis, where reduced Reelin expression contributes to synaptic dysfunction, amyloid pathology, and cognitive decline [@botellalpez2006][@tewari2019].
Reelin is one of the largest secreted proteins known, containing 3,460 amino acids with a complex domain organization [@darcangelo1995][@borrell2007]:
Reelin is proteolytically processed into functional fragments:
Reelin's best-characterized function is in cortical lamination [@darcangelo1995][@tremblay2007]:
The mechanism involves:
In the adult brain, Reelin modulates critical synaptic functions [@weeber2002][@soca2017]:
Reelin continues to function in the adult brain [@niu2008]:
Reelin affects neuronal signaling properties [@bauer2012]:
Reelin is significantly implicated in AD pathogenesis through multiple mechanisms [@botellalpez2006][@tewari2019][@krishnan2021]:
Reelin interacts with tau pathology in AD [@courtes2021]:
The ApoE receptors (Apoer2/LRP8 and VLDLR) mediate Reelin effects [@herz2007]:
Reelin modulates cytoskeletal dynamics [@gong2007]:
Reelin is strongly implicated in schizophrenia [@grayson2005][@fatemi2005]:
Approaches to restore Reelin function [@barone2020][@mukherjee2022]:
Reelin as a biomarker: